The fate of donor T-cell receptor transgenic T cells with known host antigen specificity in a graft-versus-host disease model

Transplantation

Volumn 68, Issue 1, 1999, Pages 141-149

  Dey, Bimalangshu ^a   Yang, Yong Guang ^a   Preffer, Frederic ^a   Shimizu, Akira ^a   Swenson, Kirsten ^a   Dombkowski, David ^a   Sykes, Megan ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALLOANTIGEN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN SPECIFICITY; APOPTOSIS; ARTICLE; BONE MARROW TRANSPLANTATION; CELL ACTIVATION; CELL SURVIVAL; CYTOLYSIS; DOWN REGULATION; FLOW CYTOMETRY; GENE EXPRESSION; GRAFT VERSUS HOST REACTION; IMMUNOSUPPRESSIVE TREATMENT; MAJOR HISTOCOMPATIBILITY COMPLEX; MOUSE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; T LYMPHOCYTE RECEPTOR GENE;

EID: 0033565522     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-199907150-00026     Document Type: Article

References (56)

1. Moller G. Graft versus host reaction. Immunol Rev 1985; 88: 1.
2. Vallera DA, Soderling CCB, Carlson GJ, Kersey JH. Bone marrow transplantation across major histocompatibility barriers in mice. II. T cell requirement for engraftment in total lymphoid irradiation-conditioned recipients. Transplantation 1982; 33: 243.
3. Korngold R, Sprent J. Surface markers of T cells causing lethal graft-vs-host disease to class I vs class II H-2 differences. J Immunol 1985; 135: 3004.
4. Sprent J, Schaefer M, Lo D, Korngold R. Properties of purified T cell subsets. II. In vivo responses to class I vs. class II H-2 differences. J Exp Med 1986; 163: 998.
5. Webb SR, Morris C, Sprent J. Extrathymic tolerance of mature T cells: clonal elimination as a consequence of immunity. Cell 1990; 63: 1249.
6. Rocha B, Von Boehmer H. Peripheral selection of the T cell repertoire. Science 1991; 251: 1225.
7. Hakim FT, Payne S, Shearer GM. Recovery of T cell populations after acute graft-vs-host reaction. J Immunol 1994; 152: 58.
8. Renno T, Hahne M, Tschopp J, Macdonald HR. Peripheral T cells undergoing superantigen-induced apoptosis in vivo express B220 and upregulate Fas and Fas ligand. J Exp Med 1996; 183: 431.
9. Hayden KA, Tough DF, Webb SR. In vivo response of mature T cells to Mls antigens. J Immunol 1996; 156: 48.
10. Russell JH. Activation-induced death of mature T cells in the regulation of immune responses. Curr Opin Immunol 1995; 7: 382.
11. Sprent J, Webb S. Intrathymic and extrathymic clonal deletion of T cells. Curr Opin Immunol 1995; 7: 196.
12. Webb SR, Hutchinson J, Hayden K, Sprent J. Expansion/deletion of mature T cells exposed to endogenous superantigens in vivo. J Immunol 1994; 152: 586.
13. Schonrich G, Kalinke U, Malissen M, et al. Down-regulation of T cell receptors on self-reactive T cells as a novel mechanism for extrathymic tolerance induction. Cell 1991; 65: 293.
14. Rocha B, Grandien A, Freitas AA. Anergy and exhaustion are independent mechanisms of peripheral T cell tolerance. J Exp Med 1995; 181: 993.
15. Kranz DM, Sherman DH, Sitkowsky MV, Pasternack MS, Eisen HN. Immunoprecipitation of cell surface structures of cloned cytotoxic T lymphocytes by clone-specific antisera. Proc Natl Acad Sci USA 1984; 81: 573.
16. Sha WC, Nelson CA, Newberry RD, Kranz DM, Russell RD, Loh DY. Selective expression of an antigen receptor on CD8-bearing T lymphocytes in transgenic mice. Nature 1988; 335: 271.
17. Sha WC, Nelson CA, Newberry RD, Kranz DM, Russell JH, Loh DY. Positive and negative selection of an antigen receptor on T cells in transgenic mice. Nature 1988; 336: 73.
18. Lee NA, Loh DY, Lacy E. CD8 surface levels alter the fate of α/β T cell receptor-expressing thymocytes in transgenic mice. J Exp Med 1992; 175: 1013.
19. Robey EA, Ramsdell F, Kioussis D, et al. The level of CD8 expression can determine the outcome of thymic selection. Cell 1992; 69: 1089.
20. Sykes M, Romick ML, Sachs DH. Interleukin 2 prevents graft-vs-host disease while preserving the graft-vs-leukemia effect of allogeneic T cells. Proc Natl Acad Sci USA 1990; 87: 5633.
21. Sykes M, Romick ML, Hoyles KA, Sachs DH. In vivo administration of interleukin 2 plus T cell-depleted syngeneic marrow prevents graft-versus-host disease mortality and permits alloengraftment. J Exp Med 1990; 171: 645.
22. Unkeless JC. Characterization of a monoclonal antibody directed against mouse macrophage and lymphocyte Fc receptors. J Exp Med 1979; 150: 580.
23. Preffer FL. Diagonostic cytometry. In: Diagnostic immunopathology. Colvin RB, Bhan AK, McConahey PJ, eds. New York: Raven Press, 1993; 725.
24. Schmid H, Knoll I, Uitten W, Bogart CH, et al. Cytometry 1992; 13: 204.
25. Hiromatsu K, Matsuzaki G, Tauchi Y, Yoshikai Y, Nomoto K. Sequential analysis of T cells in the liver during murine listerial infection. J Immunol 1992; 149: 568.
26. Kubo RT, Born W, Kappler JW, Marrack P, Pigeon M. Characterization of a monoclonal antibody which detects all murine alpha-beta T cell receptors. J Immunol 1989; 142: 2736.
27. Burkly LC, Lo D, Kanagawa O, Brinster RL, Flavell RA. T-cell tolerance by clonal anergy in transgenic mice with non-lymphoid expression of MHC class II I-E. Nature 1989; 342: 564.
28. Zhang L, Fung-Leung W. Miller RG. Down-regulation of CD8 on mature antigen-reactive T cells as a mechanism of peripheral tolerance. J Immunol 1995; 155: 3464.
29. Schwartz RH. A cell culture model for T lymphocyte clonal anergy. Science 1990; 248: 1349.
30. Rocha B, Tanchot C, Von Boehmer H. Clonal anergy blocks in vivo growth of mature T cells and can be reversed in the absence of antigen. J Exp Med 1993; 177: 1517.
31. Zhang L, Martin DR, Fung-Leung W-P, Teh H-S, Miller RG. Peripheral deletion of mature CDS+ antigen-specific T cells after in vivo exposure to male antigen. J Immunol 1992; 148: 3740.
32. Welsh RM, Selin LK, Razvi ES. Role of apoptosis in the regulation of virus-induced T cell responses, immune suppression, and memory. J Cell Biochem 1995; 59: 135.
33. Lohman BL, Razvi ES, Welsh RM. T-lymphocyte down-regulation after acute viral infection is not dependent on CD95 (Fas) receptor-ligand interactions. J Virol 1996; 70: 8199.
34. Razvi ES, Jiang Z, Woda BA, Welsh RM. Lymphocyte apoptosis during the silencing of the immune response to acute viral infections in normal, lpr, and Bcl-2-transgenic mice. Am J Pathol 1995; 147: 79.
35. Asano MS, Ahmed R. CD8 T cell memory in B cell-deficient mice. J Exp Med 1996; 183: 2165.
36. Ahmed R, Gray D. Immunological memory and protective immunity: understanding their relation. Science 1996; 272: 54.
37. Lau LL, Jamieson BD, Somasundaram T, Ahmed R. Cytotoxic T-cell memory without antigen. Nature 1994; 369: 648.
38. Zhang L. The fate of adoptively transferred antigen-specific T cells in vivo. Eur J Immunol 1996; 26: 2208.
39. Zhang L, Miller RG, Zhang J. Characterization of apoptosis-resistant antigen-specific T cells in vivo. J Exp Med 1996; 183: 2065.
40. Renno T, Hahne M, Macdonald HR. Proliferation is a prerequisite for bacterial superantigen-induced T cell apoptosis in vivo. J Exp Med 1995; 181: 2283.
41. Rammensee H-G, Kroschewski R, Frangoulis B. Clonal anergy induced in mature VB6+ T lymphocytes on immunizing Mls-1b mice with Mls-1a expressing cells. Nature 1989; 339: 541.
42. Rellahan BL, Jones LA, Kruisbeek AM, Fry AM, Matis LA. In vivo induction of anergy in peripheral Vβ8+ cells by staphylococcal enterotoxin B. J Exp Med 1990; 172: 1091.
43. Morecki S, Leshem B, Eid A, Slavin S. Alloantigen persistence in induction and maintenance of transplantation tolerance. J Exp Med 1987; 165: 1468.
44. Matzinger P, Guerder S. A fail-safe mechanism for maintaining self-tolerance. J Exp Med 1992; 176: 553.
45. Kirberg J, Bruno L, Von Boehmer H. CD4+ 8-help prevents rapid deletion of CD8+ cells after a transient response to antigen. Eur J Immunol 1993; 23: 1963.
46. Chen F-L, Kung JT. Deficient CD4+ T cell proliferation in the class I MHC-restricted 2C TCR-transgenic mouse. J Immunol 1996; 156: 2036.
47. Lanzavecchia A, Viola A. T cell activation determined by T cell receptor number and tunable thresholds. Science 1996; 273: 104.
48. Moskophidis D, Lechner F, Pircher H, Zinkernagel RM. Virus persistence in acutely infected immunocompetent mice by exhaustion of antiviral cytotoxic effector T cells. Nature 1993; 362: 758.
49. Butz EA, Bevan MJ. Massive expansion of antigen-specific CDS+ T cells during an acute virus infection. Immunity 1998; 8: 167.
50. Tucek-Szabo CL, Andjelic S, Lacy E, Elkon KB, Nikolic-Zugic J. Surface T cell Fas receptor/CD95 regulation, in vivo activation, and apoptosis. J Immunol 1996; 156: 192.
51. Zheng L, Fisher G, Miller RE, Peschon J, Lynch DH, Lenardo MJ. Induction of apoptosis in mature T cells by tumor necrosis factor. Nature 1995; 377: 348.
52. Sprent J, Schaefer M, Gao E, Korngold R. Role of T cell subsets in lethal graft-versus host disease (GVHD) directed to class I versus class II H-2 differences. I .L3T4+ cells can either augment or retard GVHD elicited by Lyt-2+ cells in class I-different hosts. J Exp Med 1988; 167: 556.
53. Sprent J, Schaefer M, Korngold R. Role of T cell subsets in lethal graft-versus-host disease (GVHD) directed to class I versus class II H-2 differences. J Immunol 1990; 144: 2946.
54. Sykes M, Harty MW, Pearson DA. Strain dependence of IL-2-induced GVHD protection: evidence that IL-2 inhibits selected CD4 functions. J Immunother 1994; 15: 11.
55. + T cell activity. J Immunol 1993; 150: 197.
56. Sykes M, Harty MW, Szot GL, Pearson DA. Interleukin-2 inhibits graft-versus-host disease-promoting activity of CD4+ cells while preserving CD4- and CD8-mediated graft-versus-leukemia effects. Blood 1994; 83: 2560.